D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
Student Name
Western Governors University
D027 Advanced Pathopharmacological Foundations
Prof. Name
Date
D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
Patient Overview: Dr. Anita Douglas
Who is the patient?
Dr. Anita Douglas is a 72-year-old African American woman who lives with her spouse in a home setting. She is retired and previously worked as a Veterinary Chief. Her age, ethnicity, and occupational history provide important context for evaluating her health and planning her treatment, as they influence lifestyle factors and potential risk profiles.
Presenting Complaints and Symptom History
What symptoms is the patient currently experiencing?
Dr. Douglas presents with symptoms that began recently, including a one-day history of fever. She has also experienced nasal congestion for three days, producing yellow-green mucus. Additionally, she reports a productive cough with rust-colored sputum and localized pain in the right lower chest, which worsens with coughing or deep breaths. Systemic symptoms such as fatigue and muscle soreness are also noted, suggesting the infection is affecting her overall wellbeing.
Lifestyle and Activity Patterns
What is Dr. Douglas’s level of physical activity?
Her physical activity is relatively light, involving walking for about 10 minutes two to three times each week. This limited level of activity may affect her cardiovascular fitness and recovery rate.
What dietary habits does she follow?
Dr. Douglas maintains a lacto-ovo vegetarian diet, which includes dairy products and eggs but excludes meat. This dietary pattern may impact her nutritional intake, particularly protein and certain micronutrients, which could influence immune function and healing.
Vaccinations and Allergy Status
| Vaccination | Date Administered |
|---|---|
| Influenza | 3 months ago |
| Pneumococcal | 12 years ago |
Does Dr. Douglas have any known allergies?
She has no known drug allergies (NKDA) or food allergies (NKFA). This absence of allergies simplifies the selection and administration of pharmacological treatments.
Medical History and Current Medications
What are the significant medical conditions in Dr. Douglas’s history?
Dr. Douglas’s medical background includes chronic kidney disease stage 2 (CKD-2), which has been present for nine years. She also has pulmonary hypertension (P-HTN) and hypertension (HTN), both ongoing for 14 years. These chronic illnesses require careful medication management to avoid complications.
Which medications and supplements is she currently using?
| Medication/Supplement | Dose/Frequency | Purpose |
|---|---|---|
| Trandolapril/Verapamil | 2 mg / 180 mg daily | Blood pressure control |
| Chlorothiazide | 500 mg twice daily | Diuretic for hypertension |
| Aspirin | 325 mg as needed | Pain relief and anti-inflammatory |
| Calcium | 1200 mg daily | Supports bone health |
| Vitamin D | 15 mcg daily | Bone and immune support |
Does Dr. Douglas smoke or consume alcohol?
She is a non-smoker, consumes alcohol occasionally (1-2 glasses of wine per week), and reports no use of illicit substances.
Diagnosis
What is the confirmed diagnosis for Dr. Douglas?
The confirmed diagnosis is Community-Acquired Pneumonia (CAP). CAP is a common infection affecting the lungs, often caused by bacterial or viral pathogens, characterized by symptoms such as fever, productive cough, and chest discomfort.
Discharge Treatment Plan
What instructions have been provided for Dr. Douglas’s care post-discharge?
| Instruction | Details |
|---|---|
| Rest | Ensure 8 hours of restful sleep each night |
| Hydration | Increase fluid intake to at least 64 ounces daily |
| Antibiotic Therapy | Begin treatment with Amoxicillin/Clavulanate and Doxycycline |
| Medication Adjustment | Discontinue Aspirin |
| Pain and Fever Management | Use Tylenol (acetaminophen) as needed |
| Treatment Compliance | Complete the entire prescribed course of antibiotics |
| Missed Dose Protocol | Take a missed dose immediately once remembered |
Prescription Details
| Medication | Dose/Instructions |
|---|---|
| Amoxicillin/Clavulanate | 500 mg/125 mg orally every 12 hours for 5 days (10 capsules). Take with water before or after meals; do not crush or chew. |
| Doxycycline | 100 mg orally every 12 hours for 5 days (10 capsules). Take on an empty stomach (1 hour before or 2 hours after food). Drink plenty of fluids to prevent throat irritation. |
Important Medication Precautions
What precautions should Dr. Douglas follow with her medications?
It is important that doses are evenly spaced approximately every 12 hours, ideally in the morning and evening. Strict adherence to medication instructions is critical. If any allergic reactions occur, such as hives, rash, swelling, difficulty swallowing or breathing, or chest pain, she must immediately stop the medication and seek emergency medical care.
Follow-Up and Emergency Guidance
When should Dr. Douglas seek further medical assistance?
A follow-up appointment is scheduled one week after discharge to assess recovery progress. However, if symptoms worsen or new symptoms arise, she should promptly visit a healthcare provider or the emergency room, especially after clinic hours.
References
Centers for Disease Control and Prevention. (2023). Community-Acquired Pneumonia (CAP). Retrieved from https://www.cdc.gov/pneumonia/community-acquired.html
Musher, D. M., & Thorner, A. R. (2014). Community-acquired pneumonia. New England Journal of Medicine, 371(17), 1619–1628. https://doi.org/10.1056/NEJMra1312885
Smith, R. J., & Smith, T. L. (2021). Management of bacterial pneumonia in adults. American Family Physician, 104(10), 1055–1063.
Get WGU Free MSN Samples
D024
- D024 SEI Skill Sets Discussion – Self-Awareness & Management Insights
- D024 Phase 1 Video Reflection
- D024 CPE Schedule and SEI Reflection Report
- D024 FAQ: Submission and CPE Record Guidance
- D024 Phase 1 Reflection on Leadership and Growth Strategies
- D024 Joy in the Workplace: Force Field Analysis Summary
- D024 Professional Presence & Influence: CPE Record Template Task 1
D025
- D025 Phase 2 Reflection: Insights on Team Leadership and Advocacy
- D025: Phase 1 Reflection on Health Policy Advocacy Insights
- D025 Task 1: Clinical Practice Experience
- D025 Task 1 ISBAR Summary
- D025 Final Exam: Advocacy for Policy Change in Community Health
- D025 Task 2 Advocating for Policy Change to Improve Health Outcomes in the Community
D026
D027
- D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects
- D027 OA Final Exam Study Guide: Key Concepts and Conditions
- D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
- D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
- D027 – Comprehensive Study Guide for Health Disorders and Treatments
- D027 E-Portfolio: Advanced Pathopharmacological Foundations
- D027 Study Guide – Advanced Pathopharmacology Notes
D028
D029
- D029 Narrative Essay: Innovations in Nursing Informatics
- D029 CPE Phase 2
- D029 Emerging Tech Annotated Bibliography for Nursing Care
- D029 Annotated Bibliography
- D029 Population Health Data Paper
- D029 Task 1 E-Portfolio: Clinical Practice Experience Analysis
- D029 Task 1: Analyzing Population Health Data in Strafford Country
D030
D031